Get the Stockscreener App
0.852
3.90%
-0.0346
After Hours:
1.96
1.108
+130.05%
Neuroone Medical Technologies Corp stock is traded at $0.852, with a volume of 267.21K.
It is down -3.90% in the last 24 hours and up +25.29% over the past month.
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
See More
Previous Close:
$0.8866
Open:
$0.89
24h Volume:
267.21K
Relative Volume:
1.09
Market Cap:
$42.44M
Revenue:
$2.82M
Net Income/Loss:
$-13.47M
P/E Ratio:
-1.2529
EPS:
-0.68
Net Cash Flow:
$-13.61M
1W Performance:
-5.33%
1M Performance:
+25.29%
6M Performance:
-25.91%
1Y Performance:
+5.98%
1-Day Range:
$0.823
$0.9197
1-Week Range:
$0.8106
$1.04
52-Week Range:
$0.3954
$1.39
Neuroone Medical Technologies Corp Stock (NMTC) Company Profile
Name
Neuroone Medical Technologies Corp
Sector
Industry
Phone
(952) 426-1383
Address
7599 ANAGRAM DR, EDEN PRAIRIE
Compare NMTC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 0.99 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
0.60 | 689.87M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.31 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.66 | 116.39M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.1614 | 348.41M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.47 | 0 | 0 | 0 | 0 | 0.00 |
Neuroone Medical Technologies Corp Stock (NMTC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-05-25 | Initiated | Ladenburg Thalmann | Buy |
| Mar-29-22 | Downgrade | Craig Hallum | Buy → Hold |
Neuroone Medical Technologies Corp Stock (NMTC) Latest News
How did NMTC's Q1 2025 EPS surprise investors? - AInvest
What technical models suggest about NeuroOne Medical Technologies Corporation’s comebackFree Daily Picks With Predictable Performance - Newser
Is NeuroOne Medical Technologies Corporation forming a bottoming baseProven Trading System with Consistent Gains - Newser
What indicators show strength in NeuroOne Medical Technologies Corporation Investment Life Cycle Planning Summary - Newser
Does NeuroOne Medical Technologies Corporation stock perform well during market downturnsTrack high-yield stocks before they peak - jammulinksnews.com
What is the dividend policy of NeuroOne Medical Technologies Corporation stockGet timely alerts on market movers - jammulinksnews.com
What makes NeuroOne Medical Technologies Corporation stock price move sharplyBuild a portfolio that withstands market volatility - jammulinksnews.com
How volatile is NeuroOne Medical Technologies Corporation stock compared to the marketIdentify breakout stocks before they peak - jammulinksnews.com
NeuroOne Medical Technologies Corporation Stock Chart Analysis: Bullish or Bearish Pattern FormingHigh Accuracy Alerts - Newser
What are NeuroOne Medical Technologies Corporation company’s key revenue driversTriple-digit wealth increases - jammulinksnews.com
Critical Contrast: So-Young International (NASDAQ:SY) vs. NeuroOne Medical Technologies (NASDAQ:NMTC) - Defense World
What drives NeuroOne Medical Technologies Corporation stock priceOverwhelming financial success - Autocar Professional
NeuroOne receives USPTO patent allowance for neural probe technology By Investing.com - Investing.com Nigeria
NeuroOne Medical Technologies Secures Notice of Allowance for Key Neural Probe Patent - Quiver Quantitative
NeuroOne receives patent allowance for neural probe technology - Investing.com
NeuroOne Strengthens Neural Tech Leadership with Strategic USPTO Patent for Advanced Electrode Technology - Stock Titan
What analysts say about NeuroOne Medical Technologies Corporation stockOverwhelming profit margins - Autocar Professional
Is NeuroOne Medical Technologies Corporation a good long term investmentBreakout profit opportunities - jammulinksnews.com
NeuroOne Medical Technologies Corporation Stock Analysis and ForecastAccelerated investment success - jammulinksnews.com
81,000 Shares in NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Bought by Cambridge Investment Research Advisors Inc. - Defense World
Why NeuroOne Medical Technologies Corporation stock attracts strong analyst attentionBreakout Momentum Stocks - Newser
How NeuroOne Medical Technologies Corporation stock performs during market volatilityHigh Return Intraday Picks - Newser
Revolutionary OneRF Treatment Transforms Patient's Life: From 10 Daily Seizures to Complete Freedom for 1 Year - Stock Titan
Certain Warrants of NeuroOne Medical Technologies Corporation are subject to a Lock-Up Agreement Ending on 19-JUN-2025. - MarketScreener
Certain Common Stock of NeuroOne Medical Technologies Corporation are subject to a Lock-Up Agreement Ending on 19-JUN-2025. - MarketScreener
Jane Street Group LLC Takes $33,000 Position in NeuroOne Medical Technologies Co. (NASDAQ:NMTC) - Defense World
NeuroOne Medical (NMTC) Enhances Leadership with New General Cou - GuruFocus
NeuroOne Cuts Legal Costs with Strategic General Counsel Hire: Former Partner Joins Executive Team - Stock Titan
NeuroOne CEO to Meet Investors at MedInvest Conference: Spotlight on Neural Surgery Innovation - Stock Titan
NeuroOne Medical Technologies (NASDAQ:NMTC) Trading 1.1% Higher – Should You Buy? - Defense World
NeuroOne Completes FDA Submission for OneRF Trigeminal Nerve Ablation System - Medical Product Outsourcing
NeuroOne Medical Technologies Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
NMTC Achieves Growth in Q2 with Advancements in OneRF Technology - GuruFocus
Earnings call transcript: NeuroOne Medical beats EPS expectations in Q1 2025 - Investing.com Canada
NeuroOne Medical Technologies Corp (NMTC) Q2 2025 Earnings Call Highlights: Revenue Surge and ... - Yahoo Finance
NeuroOne Medical Technologies Corp (NMTC) Q2 2025 Earnings Call - GuruFocus
NeuroOne Medical Technologies Corp Reports Q2 FY2025 Earnings: E - GuruFocus
NEUROONE MEDICAL TECHNOLOGIES Corp SEC 10-Q Report - TradingView
NeuroOne® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6% - Stock Titan
NeuroOne Medical (NMTC) Welcomes New Chief Medical Advisor | NMT - GuruFocus
NeuroOne Medical Technologies (NMTC) Appoints New Chief Medical Advisor - GuruFocus
NeuroOne appoints Dr. Patil as Chief Medical Advisor - Investing.com
NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical Advisor - Stock Titan
NeuroOne Medical Opens Exclusive Investor Access: CFO Hosts One-on-One Meetings at Plaza Hotel - Stock Titan
NeuroOne Medical Announces Participation in The D. Boral Capital Inaugural Global Conference - The Kingston Whig Standard
NeuroOne Medical Tech (NMTC) Coverage Initiated by Ladenburg Tha - GuruFocus
This Okta Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Geode Capital Management LLC Grows Stake in NeuroOne Medical Technologies Co. (NASDAQ:NMTC) - Defense World
Neuroone Medical Technologies Corp Stock (NMTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.71%
1.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):